Literature DB >> 6086841

Enkephalinergic markers in substantia nigra and caudate nucleus from Parkinsonian subjects.

C Llorens-Cortes, F Javoy-Agid, Y Agid, H Taquet, J C Schwartz.   

Abstract

Marked reductions in opiate receptor binding (-42%), "enkephalinase" activity (-39%), and Met5-enkephalin levels (-72%) accompanied the well-established dopamine depletion in the substantia nigra pars compacta of Parkinsonian subjects. In contrast, enkephalinergic markers were not significantly modified in caudate nucleus.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6086841     DOI： 10.1111/j.1471-4159.1984.tb12812.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN： 0022-3042            Impact factor:   5.372


  4 in total

Review 1.  Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.

Authors:  A Leake; I N Ferrier
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

2.  Striatal preproenkephalin gene expression is upregulated in acute but not chronic parkinsonian monkeys: implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatology.

Authors:  J S Schneider; E Decamp; T Wade
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

3.  Morphine, D-Pen2, D-Pen5 enkephalin and U50,488H differentially affect the locomotor activity and behaviours induced by quinpirole in guinea-pigs.

Authors:  P J Brent; G Bot
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  C-type natriuretic peptide in Parkinson's disease: reduced secretion and response to deprenyl.

Authors:  E A Espiner; J C Dalrymple-Alford; T C R Prickett; Y Alamri; T J Anderson
Journal:  J Neural Transm (Vienna)       Date:  2013-12-05       Impact factor: 3.575
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.